F.D.A. Backtracks and Returns Dizziness Drug to Market After Complaints

Friday, September 3, 2010 - 20:00 in Psychology & Sociology

The recall for the drug midodrine has been removed, F.D.A. officials announced, as a result of patient demand to keep it on the market.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net